Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients

被引：11
|
作者：
Salvini, Marco [1 ]
Damonte, Camilla [2 ]
Mortara, Lorenzo [3 ]
Maggi, Fabrizio [1 ,2 ]
Bruno, Antonino [3 ,4 ]
Pellegrini, Giacomo [1 ,5 ]
Mora, Barbara [1 ,2 ]
Brociner, Marco [1 ]
Ingrassia, Alessia [1 ]
Mattarucchi, Roberta [1 ]
Bianchi, Benedetta [1 ]
Sirocchi, Davide [1 ]
Agnoli, Stefania [1 ]
Rumi, Elisa [6 ,7 ]
Merli, Michele [1 ]
Fossati, Alessandro [1 ]
Bassi, Susanna [1 ]
Bombelli, Raffaella [3 ]
Gallazzi, Matteo [3 ]
Borsani, Oscar [7 ]
Baj, Andreina [1 ,2 ]
Franchi, Matteo [5 ,8 ]
Grossi, Paolo A. [1 ,2 ]
Passamonti, Francesco [1 ,2 ]
机构：
[1] ASST Sette Laghi, Osped Circolo, Varese, Italy
[2] Univ Insubria, Dept Med & Surg, Varese, Italy
[3] Univ Insubria, Dept Biotechnol & Life Sci, Lab Immunol & Gen Pathol, Varese, Italy
[4] IRCCS MultiMed, Milan, Italy
[5] Univ Milano Bicocca, Natl Ctr Healthcare Res & Pharmacoepidemiol, Milan, Italy
[6] Fdn IRCCS Policlin San Matteo, Hematol, Pavia, Italy
[7] Univ Pavia, Dept Mol Med, Pavia, Italy
[8] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Unit Biostat Epidemiol & Publ Hlth, Milan, Italy
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2022年 / 97卷 / 08期
关键词：
D O I：
10.1002/ajh.26629
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E321 / E324
页数：4
相关论文
共 50 条
  • [1] Anti-SARS-CoV-2 vaccination immune response in MS patients: interim results of a multicentre, prospective cohort study
    Berthele, A.
    Goedel, C.
    Kallmann, B.
    Kowarik, M.
    Lehmann-Horn, K.
    Marziniak, M.
    Meyer, C.
    Rauer, S.
    Rothhammer, V.
    Sprenger, T.
    Wildemann, B. C.
    Schirduan, K.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 940 - 941
  • [2] Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies
    Re, Daniel
    Barriere, Jerome
    Chamorey, Emmanuel
    Delforge, Margaux
    Gastaud, Lauris
    Petit, Emmanuel
    Chaminade, Axel
    Verriere, Benjamin
    Peyrade, Frederic
    LEUKEMIA & LYMPHOMA, 2021, 62 (13) : 3308 - 3310
  • [3] Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients
    Pascale, Sara Pasquina
    Nuccorini, Roberta
    Pierri, Teresa
    Di Mare, Roberta
    Fabio, Lucia
    Lerose, Emilia
    Merlino, Maria Antonietta
    Schiavo, Pietro
    Amendola, Angela
    Brucoli, Gino
    Caputo, Maria Denise
    Chitarrelli, Ida
    Cimminiello, Michele
    Coluzzi, Sabrina
    Filardi, Nunzio Biagio
    Matturro, Angela
    Vertone, Domenico
    Poggiaspalla, Monica
    Malaspina, Francesco
    Musuraca, Gerardo
    Coralluzzo, Gennaro
    Mannarella, Clara
    Musto, Clelia
    Bellettieri, Angela Pia
    Martinelli, Giovanni
    Cerchione, Claudio
    Pizzuti, Michele
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Immunogenicity and Safety of Anti-SARS-CoV-2 mRNA Vaccines in a Cohort of Patients with Hereditary Angioedema
    Mormile, Ilaria
    Gigliotti, Maria Celeste
    Petraroli, Angelica
    Cocchiaro, Antonio
    Furno, Alessandro
    Granata, Francescopaolo
    Rossi, Francesca Wanda
    Portella, Giuseppe
    de Paulis, Amato
    VACCINES, 2023, 11 (02)
  • [5] Efficacy, Safety and Immunogenicity of Anti-SARS-CoV-2 Vaccines in Patients with Cirrhosis: A Narrative Review
    Toutoudaki, Konstantina
    Dimakakou, Melitini
    Androutsakos, Theodoros
    VACCINES, 2023, 11 (02)
  • [6] IMMUNOGENICITY AND SAFETY PROSPECTIVE STUDY OF ANTI-SARS-CoV-2 MRNA VACCINATION IN A REAL-LIFE SETTING OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
    Ferraioli, M.
    Prevete, I.
    Chimenti, M. S.
    De Marco, L.
    Meschi, S.
    Mariotti, D.
    Aiello, A.
    Vanini, V.
    Cuzzi, G.
    Salmi, A.
    Maggi, F.
    Goletti, D.
    Sebastiani, G. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 : 1268 - 1269
  • [7] Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia
    Crickx, Etienne
    Moulis, Guillaume
    Ebbo, Mikael
    Terriou, Louis
    Briantais, Antoine
    Languille, Laetitia
    Limal, Nicolas
    Guillet, Stephanie
    Michel, Marc
    Mahevas, Matthieu
    Godeau, Bertrand
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (05) : 703 - 705
  • [8] Effects of Sirolimus on Anti-SARS-CoV-2 Vaccination in Patients With Lymphangioleiomyomatosis
    Worthy, Tat'Yana
    Jones, Amanda
    Yang, Bennett E.
    Ishiwata-Endo, Hiroko
    Gupta, Nishant
    Moss, Joel
    CHEST, 2024, 165 (02) : 303 - 306
  • [9] Anti-SARS-CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 vaccination
    Rasmussen, Magnus
    Neumann, Ariane
    Moghaddassi, Mahnaz
    Inghammar, Malin
    Bjork, Jonas
    Malmqvist, Ulf
    Kahn, Fredrik
    INFECTIOUS DISEASES, 2025,
  • [10] Antibody responses to SARS-CoV-2 Omicron infection in patients with hematological malignancies: A multicenter, prospective cohort study
    Li, Jun
    Liu, Yi
    Wei, Xia
    Liu, Zhanshu
    Yang, Zailiang
    Liu, Ling
    Zhou, Meiyu
    Xu, Guofa
    Chen, Lanting
    Ding, Yao
    Lei, Haike
    Yang, Zailin
    Chen, Shuang
    Zhang, Xiaomei
    Tang, Yifeng
    Fu, Huihui
    He, Sanxiu
    Guo, Bingling
    Liang, Xiping
    Zhang, Lingqian
    Zhang, Wenjun
    Wu, Jing
    Wang, Chaoyu
    Hu, Chongling
    Hu, Renzhi
    Luo, Xin
    Quan, Xi
    Zeng, Chensi
    Liang, Shunsi
    Liu, Tingting
    Lv, Jing
    Luo, Qin
    Qi, Qin
    Xu, Luxiang
    Xiong, Yan
    Liu, Jueyin
    Huang, Dehong
    Xiao, Chunyan
    Liu, Jun
    Yang, Tao
    Xiang, Ying
    Li, Qiying
    Nan, Yingyu
    Li, Jieping
    Zhang, Yong
    Wu, Yongzhong
    Liu, Yao
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (12)
12345